193 related articles for article (PubMed ID: 17885669)
21. Comparative expression profile of CD10 and cyclin D1 in cutaneous histiocytofibroma and dermatofibrosarcoma.
Kouki N; Ben Rejeb S; Cherif I; Ghozzi A; Chelly I; Bellil K; Haouet S
J Immunoassay Immunochem; 2021 Jul; 42(4):347-358. PubMed ID: 33444077
[TBL] [Abstract][Full Text] [Related]
22. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
Zelger BW; Ofner D; Zelger BG
Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
Garcia C; Viehman G; Hitchcock M; Clark RE
Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
[TBL] [Abstract][Full Text] [Related]
24. Possible contribution of PDGF-BB-induced autophagy in dermatofibrosarcoma protuberans: Autophagy marker Atg5 could be a differential marker between dermatofibrosarcoma protuberans and dermatofibroma.
Motegi SI; Fujiwara C; Sekiguchi A; Yamazaki S; Yokoyama Y; Yasuda M; Ishikawa O
J Dermatol Sci; 2019 Feb; 93(2):139-141. PubMed ID: 30704939
[No Abstract] [Full Text] [Related]
25. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
[TBL] [Abstract][Full Text] [Related]
26. Superficial Acral Fibromyxoma: Report of 13 Cases With New Immunohistochemical Findings.
Cullen D; Díaz Recuero JL; Cullen R; Rodríguez Peralto JL; Kutzner H; Requena L
Am J Dermatopathol; 2017 Jan; 39(1):14-22. PubMed ID: 28045748
[TBL] [Abstract][Full Text] [Related]
27. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
[TBL] [Abstract][Full Text] [Related]
28. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
McNiff JM; Subtil A; Cowper SE; Lazova R; Glusac EJ
J Cutan Pathol; 2005 Jul; 32(6):413-8. PubMed ID: 15953374
[TBL] [Abstract][Full Text] [Related]
29. Current topics of immunohistochemistry as applied to skin tumors.
Hashimoto K; Fujiwara K; Mehregan A
J Dermatol; 1993 Sep; 20(9):521-32. PubMed ID: 7693783
[TBL] [Abstract][Full Text] [Related]
30. Cellular digital fibromas: what about superficial acral fibromyxoma?
Guitart J; Ramirez J; Laskin WB
J Cutan Pathol; 2006 Nov; 33(11):762-3; author reply 764. PubMed ID: 17083699
[No Abstract] [Full Text] [Related]
31. Cutaneous soft tissue tumors: how do we make sense of fibrous and "fibrohistiocytic" tumors with confusing names and similar appearances?
Hornick JL
Mod Pathol; 2020 Jan; 33(Suppl 1):56-65. PubMed ID: 31653978
[TBL] [Abstract][Full Text] [Related]
32. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
34. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
Franchi A; Santucci M
Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
[TBL] [Abstract][Full Text] [Related]
35. Bednar tumor: a report of two cases.
Yagi Y; Ueda K; Maruyama S; Noborio R
J Dermatol; 2004 Jun; 31(6):484-7. PubMed ID: 15235190
[TBL] [Abstract][Full Text] [Related]
36. Subungual Acral Fibromyxoma Involving the Bone: A Mimicker of Malignancy.
Carranza C; Molina-Ruiz AM; Pérez de la Fuente T; Kutzner H; Requena L; Santonja C
Am J Dermatopathol; 2015 Jul; 37(7):555-9. PubMed ID: 25062265
[TBL] [Abstract][Full Text] [Related]
37. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
Goldblum JR; Tuthill RJ
Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
[TBL] [Abstract][Full Text] [Related]
38. Superficial acral fibromyxoma: a CD34+ periungual tumor.
Messeguer F; Nagore E; Agustí-Mejias A; Traves V
Actas Dermosifiliogr; 2012 Jan; 103(1):67-9. PubMed ID: 22445566
[No Abstract] [Full Text] [Related]
39. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
Harvell JD; Kilpatrick SE; White WL
Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.
Taniuchi K; Yamada Y; Nonomura A; Takehara K
J Cutan Pathol; 1997 Aug; 24(7):393-7. PubMed ID: 9274955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
